Open AccessMegaprosthesis Versus Allograft Prosthesis Composite for the Management of Massive Skeletal Defects: A Meta-Analysis of Comparative Studies
Author(s) -
Deepak Gautam,
Nikhil Arora,
Saurabh Kumar Gupta,
Jaiben George,
Rajesh Malhotra
Publication year - 2021
Publication title -
current reviews in musculoskeletal medicine
Language(s) - English
Resource type - Journals
eISSN - 1935-973X
pISSN - 1935-9748
DOI - 10.1007/s12178-021-09707-6
Subject(s) - prosthesis , medicine , amputation , surgery , survivorship curve , nonunion , debridement (dental) , orthopedic surgery , modalities , implant , cancer , social science , sociology
Megaprosthesis and Allograft Prosthesis Composite (APC) are the established treatment modalities for massive skeletal defects. There are a handful of studies comparing the use of megaprosthesis and APC in the management of substantial bone loss and it has always been a topic of debate regarding the superiority of one modality over the other. Therefore, we aim to compare the functional outcome and implant survivorship of each modality including complications, revision rates, amputation rate and mortality.